Tenderwize
Zurück zur Suche

Medicinal products with the active substance Testosterone (ATC: G03BA03 - in the dosage form injection solution)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Apr 29, 2028 · 612 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Testosteron (ATC: G03BA03 - in der Darreichungsform Injektionslösung)

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

60 / 100

Komplexität

20 / 100

Risikofaktoren

No estimated value or guaranteed minimum volume is provided; actual revenue may be negligible.

The buyer may terminate these non-exclusive contracts if exclusive contracts are later tendered.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of Testosterone injection (ATC G03BA03) to AOK Sachsen-Anhalt
  • Non-exclusive discount agreement under §130a SGB V
Vollständige Zusammenfassung anzeigen

This is a non-exclusive discount agreement (open-house model) under §130a SGB V for pharmaceutical products containing Testosterone (ATC G03BA03) in injection form. The buyer is AOK Sachsen-Anhalt. There is no competitive procedure; any eligible pharmaceutical company can join at any time until 2028-04-30. The contract runs for a maximum of 24 months from earliest start on 2026-07-01 to 2028-06-30. No estimated value is provided. The notice is published for transparency but is not a public procurement under EU directives.

Risiken

No estimated value or guaranteed minimum volume is provided; actual revenue may be negligible.

The buyer may terminate these non-exclusive contracts if exclusive contracts are later tendered.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must be a pharmaceutical company or consortium of such companies
  • Contract duration: max 24 months (01.07.2026 – 30.06.2028)

Administrative

  • Must request and complete the participation documents

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria specified; all eligible participants are accepted.

Auftraggeber

Ort

Magdeburg, DEU

Auftraggeberprofil

Profil öffnen

Kennung

DE258393558

Tätigkeit

Health

Lose (1)

LOT-0001

Medicinal products with the active substance Testosterone (ATC: G03BA03 - in the dosage form injection solution)

Non-exclusive discount agreements for finished medicinal products with Testosterone injection. Any pharmaceutical company that meets the participation requirements can enter into a contract at any time. No exclusivity, no individual negotiations.

SuppliesEU fundedElectronic submission

Ort

DEE03, Germany

Dauer

2 YEAR

Kategorie

Pharmaceutical products

Zuschlagskriterien

No award criteria specified; all eligible participants are accepted.

Frist

Deadline Apr 29, 2028

Vergabedetails

Veröffentlichungsdatum
12 May 2026
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
329750-2026

Dokumente (1)

Ähnliche Ausschreibungen